TP

Protagonist Therapeutics Presents Updated Phase 2 Rusfertide Data in Polycythemia Vera (PV) at ASH 2021 Annual Meeting

Retrieved on: 
Dimanche, décembre 12, 2021
Iron overload, Icahn School of Medicine at Mount Sinai, NCE, Therapy, Polycythemia, Clinical trial, Janssen, TP, Security (finance), Maintenance, MRI, Risk, Mount Sinai, Industry, Inflammatory Bowel Diseases, Psoriasis, Private Securities Litigation Reform Act, Transferrin, Society, U.S. Securities and Exchange Commission, Doctor of Philosophy, COVID-19, De novo, Hereditary haemochromatosis, UC, Company, Form 10-K, Phlebotomy, Multimedia, Șaeș, HH, View, Forward-looking statement, Hematocrit, Ulcerative colitis, Iron, ASH, Safety, Form, Nature, Quality of life, Poster, Pancreatic serous cystadenoma, Protagonist, Polycythemia vera, Pharmaceutical industry, Medical imaging, Fine chemical, Medicine, PV, MD, Patient

NEWARK, Calif., Dec. 12, 2021 /PRNewswire/ --Protagonist Therapeutics(Nasdaq: PTGX) ("Protagonist" or "the Company") today presented updated data from two ongoing Phase 2 studies evaluating rusfertide in patients with polycythemia vera (PV), demonstrating its ability to essentially eliminate the need for phlebotomies in patients.

Key Points: 
  • NEWARK, Calif., Dec. 12, 2021 /PRNewswire/ --Protagonist Therapeutics(Nasdaq: PTGX) ("Protagonist" or "the Company") today presented updated data from two ongoing Phase 2 studies evaluating rusfertide in patients with polycythemia vera (PV), demonstrating its ability to essentially eliminate the need for phlebotomies in patients.
  • Rusfertide also showed rapid and sustained hematocrit control in patients requiring frequent phlebotomies or those having high baseline hematocrit levels (>48%).
  • "The upcoming double-blinded, placebo-controlled Phase 3 PV study is a transformative step in the progressive journey of rusfertide, from de novo discovery to a registrational study.
  • In this Phase 2 study, 63 phlebotomy-dependent PV patients were treated with rusfertide for up to 18 months.

Liquidnet Enhances Continental Europe Coverage

Retrieved on: 
Jeudi, décembre 9, 2021
Networks, Finance, Data Management, Professional Services, Technology, FSP, Investment Industry Regulatory Organization of Canada, New Zealand, CMSL, London, Australian Securities and Investments Commission, Central Bank of Ireland, 2011 New Year Honours (New Zealand), Group, Financial Sector Conduct Authority (South Africa), Canadian Investor Protection Fund, Investment Commission, SIX Swiss Exchange, Data Analytics Acceleration Library, Central bank, Money, View, CMS, ICAP, Financial Conduct Authority, CEO, Warsaw Stock Exchange, Intelligence, Monetary Authority of Singapore, Securities and Futures Commission, Financial Services Agency, Finance, TP, Solution, AFSL, London Stock Exchange, Financial services, Security (finance), Liquidnet, TP ICAP Group plc, LIQUIDNET, TP ICAP GROUP PLC

Liquidnet, the global institutional investment network, today announced it has enhanced its continental European coverage by deploying specialists in equities and fixed income in Paris, Madrid, Frankfurt and Copenhagen to offer a range of execution services including client coverage, sales trading and trading.

Key Points: 
  • Liquidnet, the global institutional investment network, today announced it has enhanced its continental European coverage by deploying specialists in equities and fixed income in Paris, Madrid, Frankfurt and Copenhagen to offer a range of execution services including client coverage, sales trading and trading.
  • The strategic move taps into the existing geographic infrastructure and expertise within the pan-European TP ICAP Group allowing Liquidnet to deploy coverage teams locally to serve the buy side Member community.
  • Liquidnet is a technology-driven, global institutional investment network that intelligently connects the worlds investors to the worlds investments.
  • Liquidnet Japan Inc. is regulated by the Financial Services Agency of Japan and is a member of JSDA/JIPF.

Global AML/KYC Spending Projected to Total $1.4 Billion in 2021, Rising 26% as Governments Continue to Focus on Fighting Financial Crime - New Burton-Taylor Report

Retrieved on: 
Jeudi, décembre 2, 2021
Refinitiv, TP ICAP, Technology, LexisNexis, Industry, Overalls, Acquisition, LexisNexis Risk Solutions, AML, Data Analytics Acceleration Library, Compliance, Solution, Web data services, Money, ICAP, Research report, Research, Data, TP, NEW, Burton & Taylor, Market data, Multimedia, KYC, RELX, Growth, Cryptocurrency, Online shopping

Refinitiv remained the largest provider of AML/KYC data & services in 2021, with strong year-on-year growth boosted by the integration of recent acquisitions.

Key Points: 
  • Refinitiv remained the largest provider of AML/KYC data & services in 2021, with strong year-on-year growth boosted by the integration of recent acquisitions.
  • Dow Jones Risk & Compliance and Bureau van Dijk have the two highest 5-year CAGRs in the industry, with both companies expected to continue strong growth.
  • "Global demand for AML/KYC data and services continues to reach record levels as businesses and regulators prioritize the fight against financial crime," said Adler Smith, analyst at Burton-Taylor.
  • Burton-Taylor today announced the publication of its Anti-Money Laundering/Know-Your-Customer Data & Services Global Market Share 2021 report.

Liquidnet Appoints Global Head of Fixed Income Product, Services and Dealer Relations

Retrieved on: 
Mercredi, novembre 10, 2021
Professional Services, Data Management, Technology, Software, Finance, Networks, Internet, Latium, Intelligence, Industry, SIX Swiss Exchange, Financial Conduct Authority, Growth, GFI Group, New Zealand, Acquisition, Money, Group, TP ICAP, Central Bank of Ireland, Warsaw Stock Exchange, Capital market, FSP, EMEA, AFSL, Central bank, Investment Industry Regulatory Organization of Canada, View, CMS, Data Analytics Acceleration Library, Financial Services Agency, Finance, Investment Commission, London Stock Exchange, Financial Sector Conduct Authority (South Africa), Fixed income, Securities and Futures Commission, 2011 New Year Honours (New Zealand), TP, London, Monetary Authority of Singapore, CMSL, Canadian Investor Protection Fund, DCM, Australian Securities and Investments Commission, Security (finance), Liquidnet, TP ICAP Group plc, LIQUIDNET, TP ICAP GROUP PLC

Liquidnet, the global institutional investment network, today announced the appointment of Nicholas Stephan as Global Head of Fixed Income Product, Services and Dealer Relations.

Key Points: 
  • Liquidnet, the global institutional investment network, today announced the appointment of Nicholas Stephan as Global Head of Fixed Income Product, Services and Dealer Relations.
  • Based in New York and reporting to Mark Russell, Global Head of Fixed Income, Nick will be responsible for growing the firms fixed income offering across primary and secondary markets.
  • Mark Russell said: Liquidnet Fixed Income is in an exciting phase of growth and development.
  • Liquidnet Singapore Private Limited is regulated by the Monetary Authority of Singapore as a Capital Markets Services Licensee, CMSL number CMS 100757-1.

Envestnet Welcomes Dawn Newsome as Chief Business Operations Officer

Retrieved on: 
Lundi, novembre 1, 2021
NatWest, Royal Bank of Scotland, Technology, Entrepreneurship, TP ICAP, JPMorgan Chase, Ecosystem, Industry, TP, Family, NYSE, Leadership, Intelligence, CEO, S&P Global Ratings, Growth, Nomura, RIAS, Solution, Financial technology, Royal Bank, Financial services

CHICAGO, Nov. 1, 2021 /PRNewswire/ --Envestnet, Inc. announces that Dawn Newsome has joined the firm as Chief Business Operations Officer.

Key Points: 
  • CHICAGO, Nov. 1, 2021 /PRNewswire/ --Envestnet, Inc. announces that Dawn Newsome has joined the firm as Chief Business Operations Officer.
  • As a member of the executive team, Dawn will ensure Envestnet remains well-positioned to continue building and expanding its financial wellness network.
  • "Dawn will work across our business lines to reinforce our alignment and focus to achieve this goal.
  • I believe that Envestnet's ecosystem will continue to expand and strengthen its capabilities to support our clients and further connect the financial lives of consumers," said Dawn Newsome, Chief Business Operations Officer of Envestnet.

Reference Point Announces Two New Partner Appointments in Its Technology and Data Services Practice

Retrieved on: 
Mardi, octobre 26, 2021
Technology, TP ICAP, Industry, CIO, CIOS, Data, Organization, TP, HSBC, Citigroup, Barclays Investment Bank, View, Capital market, Accenture, Consultant, Integration Reference Point, Multimedia, Solution, Lehman Brothers, Reference Point, Management, Sales, Construction

Luke Barnett, who has more than 20 years of technology expertise, most recently served as Group CIO at TP ICAP.

Key Points: 
  • Luke Barnett, who has more than 20 years of technology expertise, most recently served as Group CIO at TP ICAP.
  • "Luke and Joseph's appointments reflect our most recent investment in broadening and deepening Reference Point's bench of financial services technology and data expertise," said Stephen Hook, Reference Point Partner and lead of the firm's Technology and Data services.
  • "I'm excited to help more companies formulate and execute large-scale technology projects in my role at Reference Point.
  • Founded in 2002, Reference Point is a strategy, management, and technology consulting firm focused on delivering impactful solutions for the financial services industry.

Reference Point Announces Two New Partner Appointments in Its Technology and Data Services Practice

Retrieved on: 
Mardi, octobre 26, 2021
Technology, TP ICAP, Industry, CIO, CIOS, Data, Organization, TP, HSBC, Citigroup, Barclays Investment Bank, Capital market, Accenture, Consultant, Integration Reference Point, Solution, Lehman Brothers, Reference Point, Management, Sales, Construction

NEW YORK, Oct. 26, 2021 /PRNewswire/ -- Further cementing its unique position as an expert- and senior practitioner-led strategy, management, and technology consulting firm for the global financial services industry, Reference Point last month announced that Luke Barnett and Joseph Lai have joined as partners in its Technology and Data Services practice.

Key Points: 
  • Luke Barnett, who has more than 20 years of technology expertise, most recently served as Group CIO at TP ICAP.
  • "Luke and Joseph's appointments reflect our most recent investment in broadening and deepening Reference Point's bench of financial services technology and data expertise," said Stephen Hook, Reference Point Partner and lead of the firm's Technology and Data services.
  • "I'm excited to help more companies formulate and execute large-scale technology projects in my role at Reference Point.
  • Founded in 2002, Reference Point is a strategy, management, and technology consulting firm focused on delivering impactful solutions for the financial services industry.

Servier announces outcome from the primary analysis of the Phase III SOLSTICE trial assessing LONSURF® (trifluridine/tipiracil) + bevacizumab in a 1st line setting for patients with unresectable mCRC non-eligible for intensive therapy

Retrieved on: 
Vendredi, octobre 22, 2021
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, VEGF, Phase, EGFR, Social, Quality of life, Cardiology, Cell proliferation, Group, Cancer, Trifluridine, Thymidine phosphorylase, Social media, Adenocarcinoma, Colorectal cancer, TP, Human, Lead, Patient, Capecitabine, Foundation, Gastrointestinal cancer, Survival rate, Taiho Pharmaceutical, Trifluridine/tipiracil, Adult, MGC, Congress, CRC, Research and development, Neuroscience, Oxaliplatin, Growth, Lists of diseases, Metabolism, Vascular endothelial growth factor A, Bevacizumab, Heart, Irinotecan, DNA, Pharmaceutical industry, Medical imaging

SOLSTICE was designed to evaluate the superiority of LONSURF (trifluridine/tipiracil) + bevacizumab over capecitabine + bevacizumab in 1st line unresectable metastatic colorectal cancer (mCRC) in patients non-eligible for intensive therapy.

Key Points: 
  • SOLSTICE was designed to evaluate the superiority of LONSURF (trifluridine/tipiracil) + bevacizumab over capecitabine + bevacizumab in 1st line unresectable metastatic colorectal cancer (mCRC) in patients non-eligible for intensive therapy.
  • D., Head of Late Stage and Life Cycle Management, and Deputy Head Oncology and Immuno-Oncology Therapeutic Area, Servier.
  • The clinical value of LONSURF in its current indications remains unchanged, and the ongoing Phase III SUNLIGHT trial (LONSURF + bevacizumab versus LONSURF in 3rd line mCRC) is proceeding as planned.
  • SOLSTICE is an open-label, randomized, multicentre Phase III trial in 856 unresectable metastatic colorectal cancer patients who are not candidates for, or do not require, intensive therapy.

Global ESG Investing Surge Drives Growth for Data and Index Providers- Two New Burton-Taylor Reports

Retrieved on: 
Mercredi, octobre 20, 2021
ICAP, Data Analytics Acceleration Library, NEW, Burton & Taylor, Data, Multimedia, ESG, Research, Industry, Market data, TP, TP ICAP, Lithium, Security (finance), Online shopping

Burton-Taylor today announced the publication of two new reports covering both the ESG index and data industries.

Key Points: 
  • Burton-Taylor today announced the publication of two new reports covering both the ESG index and data industries.
  • The ESG Index report analyzes global revenues by provider and gives insight into the drivers of ESG index growth.
  • The ESG Data/Analytics report looks at the increasing role ESG data/analytics is playing in capital markets and how data providers are reacting to the change.
  • Burton-Taylor Exchange, Index, AML/KYC, Media Intelligence/PR and Market Data share figures are seen as the industry benchmark standard globally.

Bloomberg and Kaiko Issue First Financial Instrument Global Identifiers for Crypto Assets

Retrieved on: 
Jeudi, octobre 14, 2021
Crypto, Bitcoin, Ethereum, Register, Object Management Group, Financial Instrument Global Identifier, Organization, OMG, Technology, International Securities Identification Number, Industry, Solution, DTI, Adoption, Asset, Growth, Charlotte Figi, TP, Bloomberg Terminal, ISIN, ISO, Registration authority, Efficiency, Multimedia, FIGI, Bloomberg, News, CEO, Research, Cryptocurrency, Risk management

NEW YORK, Oct. 14, 2021 /PRNewswire/ --Bloomberg and Kaiko are pleased to announce the issuance of the first series of Financial Instrument Global Identifiers covering crypto assets.

Key Points: 
  • NEW YORK, Oct. 14, 2021 /PRNewswire/ --Bloomberg and Kaiko are pleased to announce the issuance of the first series of Financial Instrument Global Identifiers covering crypto assets.
  • The Financial Instrument Global Identifier (FIGI) is an open standard of the Object Management Group (OMG), for the issuance of unique identifiers assigned to financial instruments including equities, derivatives, bonds, municipals, and currencies.
  • Today, Kaiko and Bloomberg officially released the first batch of FIGIs for all Bitcoin and Ethereum instruments denominated in fiat currencies.
  • FIGIs for crypto assets enable interoperability between industry participants such as digital asset exchanges, data aggregators, custodians, service providers, and regulators.